VABORBACTAM

This product is for research use only, not for human use. We do not sell to patients.

VABORBACTAM
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
100mg$1750To Be Confirmed
250mg$2800To Be Confirmed
500mg$4200To Be Confirmed

Cat #: V3913 CAS #: 1360457-46-0 Purity ≥ 98%

Description: Vaborbactam (formerly PX-7009; MP-7009; RPX7009; trade name: Vabomere) is novel, potent and broad spectrum non-β-lactam (cyclic boronic acid pharmacophore) β-lactamase inhibitor discovered by Rempex Pharmaceuticals and approved in 2017 for the treatment of complicated urinary tract infections and pyelonephritis.

References: Hecker SJ, et al. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases. J Med Chem. 2015 May 14;58(9):3682-92.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)297.13
Molecular FormulaC12H16BNO5S
CAS No.1360457-46-0
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: > 10mMr
Water: 30 mg/mLr
Ethanol: N/A
SMILES CodeO=C(O)C[C@@H]1CC[C@H](NC(CC2=CC=CS2)=O)B(O)O1
SynonymsRPX-7009; MP-7009; RPX7009; MP7009; REBO07; REBO 07; MP7; MP 7; RPX 7009; MP 7009; REBO-07; MP-7; Trade name: Vabomere
ProtocolIn VitroVaborbactam (RPX-7009; MP-7009) is a broad spectrum of inhibition of β-lactamases, with particularly potent activity against KPC, CTX-M, SHV, and CMY enzymes[1]. Vaborbactam restores meropenem activity for 72.7 to 98.1% of CPE isolates at ≤2 μg/mL, and maximum potentiation is achieved with fixed concentrations of ≥8 μg/mL of the inhibitor (≥96.5% of isolates are inhibited at ≤2 μg/mL of meropenem-vaborbactam). Meropenem-vaborbactam with a fixed concentration of 8 μg/mL of the inhibitor (MIC50, ≤0.06 μg/mL for all organisms) inhibits 93.7% of the CPE isolates displaying elevated meropenem MICs at ≤1 μg/mL[2]. By forming a reversible dative bond with the blactamase, vaborbactam acts as a competitive inhibitor and is not hydrolyzed by the b-lactamase[3].
In VivoVaborbactam (RPX-7009; MP-7009) is well tolerated and has a half-life of 1.23 h, and steadystate volume of distribution of 21.0 L in subjects[3].
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.3655 mL16.8277 mL33.6553 mL67.3106 mL
5mM0.6731 mL3.3655 mL6.7311 mL13.4621 mL
10mM0.3366 mL1.6828 mL3.3655 mL6.7311 mL
20mM0.1683 mL0.8414 mL1.6828 mL3.3655 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.